{"Name":"StemPar Sciences","perma":"stempar-sciences","BasicInfo":{"funded":"2009-01-01","isClosed":false,"closed":null,"short":"StemPar is developing a pipeline of powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their"},"FundingRounds":[{"funding_type":"private_equity","series":null,"announcedDate":"2013-01-02","moneyRaised":null}],"Acquisitions":[],"AcquiredBy":null,"IPO":null,"Investments":[],"Products":[],"ProductsPermas":[],"CurrentTeam":[],"PastTeam":[]}
